Macrogen, Inc. (KOSDAQ:038290)

Market Cap	169.02B
Revenue (ttm)	145.10B
Net Income (ttm)	-7.67B
Shares Out	10.84M
EPS (ttm)	-751.21
PE Ratio	n/a
Forward PE	21.96
Dividend	300.00 (1.92%)
Ex-Dividend Date	Dec 27, 2024

Volume	16,209
Average Volume	12,161
Open	15,450
Previous Close	15,380
Day's Range	15,210 - 15,450
52-Week Range	14,700 - 24,600
Beta	0.75
RSI	35.35
Earnings Date	Aug 14, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Commercial Physical and Biological Research
• Founded: 1997
• Employees: 500
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.